Basil T. Darras - Concepedia

Author

Basil T. Darras

Also Known As

Adnan Manzur, Amy Wolfe, B Darras, B T Darras, B. Darras, B. T. Darras, B.T. Darras, BASIL T. DARRAS, BT Darras, Basil Darras

516

Publications

22K

Citations

H-Index

198

Concepts

All Affiliations

Boston Children's Hospital Harvard University Stanford University Columbia University Irving Medical Center Children's Hospital of Philadelphia

About

Basil T. Darras is an author at Boston Children's Hospital specializing in medicine, health sciences, and pediatrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	67	4.5K
2	Health Sciences	16	19	1.4K
3	Engineering	4	4	127
4	Natural Sciences	4	4	139
5	Education	1	1	131

Basil T. Darras

205

Publications

18.7K

Citations

H-Index

Page 1

	Year	Citations
Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy Richard S. Finkel, Eugenio Mercuri, Basil T. Darras, New England Journal of Medicine	2017	2.2K
Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy Eugenio Mercuri, Basil T. Darras, Claudia A. Chiriboga, New England Journal of Medicine	2018	1.4K
The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Alan H. Beggs, Mary B. Moyer, S. Scherpf, PubMed	1989	961
Results from a phase 1 study of nusinersen (ISIS-SMN <sub>Rx</sub> ) in children with spinal muscular atrophy Claudia A. Chiriboga, Kathryn J. Swoboda, Basil T. Darras, Neurology	2016	591
Observational study of spinal muscular atrophy type I and implications for clinical trials Richard S. Finkel, Michael McDermott, Petra Kaufmann, Neurology	2014	506
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial John Day, Richard S. Finkel, Claudia A. Chiriboga, The Lancet Neurology Rare DiseasesSpinal Cord InjuryMedicineDegenerative DiseaseNeurology	2021	449
Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial Craig M. McDonald, Craig Campbell, Ricardo Erazo Torricelli, The Lancet Rare DiseasesUrologyClinical TrialsDegenerative DiseaseRehabilitation	2017	446
Natural history of infantile‐onset spinal muscular atrophy Stephen J. Kolb, Christopher S. Coffey, Jon Yankey, Annals of Neurology	2017	392
Risdiplam in Type 1 Spinal Muscular Atrophy Giovanni Baranello, Basil T. Darras, John Day, New England Journal of Medicine	2021	383
An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients Jessica O’Hagen, Allan M. Glanzman, Michael McDermott, Neuromuscular Disorders Stroke RehabilitationSpinal Cord InjurySma IiApplied PhysiologyRehabilitation	2007	380

Page 1